Attention deficit hyperactivity disorder

Attention deficit hyperactivity disorder (ADHD)Faraone SV, Bellgrove MA, Brikell I, Cortese S, Hartman CA, Hollis C, et al. (22 February 2024). "Attention-deficit/hyperactivity disorder". Nature Reviews Disease Primers. 10 (1): 11. doi:10.1038/s41572-024-00495-0. ISSN 2056-676X. PMID 38388701. be a neurodevelopmental disorder wey be characterized by symptoms of inattention, hyperactivity, impulsivity, den emotional dysregulation wey be excessive den pervasive, wey dey impair insyd multiple contexts, den developmentally inappropriate. ADHD symptoms dey arise from executive dysfunction.

Impairments wey dey result from deficits insyd self-regulation such as time management, inhibition, task initiation, den sustained attention fi include poor professional performance, relationship difficulties, den chaw health risks, collectively wey dey predispose to a diminished quality of life den a reduction in life expectancy. E be associated plus oda mental disorders as well as non-psychiatric disorders, wich fi cause additional impairment.Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. (September 2021). "The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder". Neuroscience & Biobehavioral Reviews. 128. Elsevier BV: 789–818. doi:10.1016/j.neubiorev.2021.01.022. ISSN 0149-7634. PMC 8328933. PMID 33549739. De disorder dey cost society hundreds of billions of US dollars each year, worldwide.

 References 

 Read further 










 External links 
 National Institute of Mental Health. NIMH Pages About Attention-Deficit/Hyperactivity Disorder (ADHD). National Institutes of Health (NIH), U.S. Department of Health and Human Services.


Category:1987 neologisms
Category:Ailments of unknown cause
Category:Amphetamine
Category:Attention disorders
Category:Learning disabilities
Category:Methylphenidate
Category:Translated from MDWiki